6400-14-2

Usage

Uses

Used in Hair Dye Industry:
2-CHLORO-M-PHENYLENEDIAMINE is used as a colorant for hair dyes due to its ability to produce vibrant and long-lasting colors. It is valued for its effectiveness in creating a wide range of hues and its contribution to the longevity of the hair color.
Used in Dye and Pigment Production:
2-CHLORO-M-PHENYLENEDIAMINE is used as an intermediate in the production of various dyes and pigments for different industries. Its chemical properties allow for the creation of a broad spectrum of colors, making it a versatile component in the formulation of colorants for textiles, plastics, and other materials.
Used in Pharmaceutical Industry:
Although not explicitly mentioned in the provided materials, 2-CHLORO-M-PHENYLENEDIAMINE, given its chemical structure, could potentially be used as a precursor in the synthesis of pharmaceutical compounds. Its reactivity and functional groups may be harnessed in the development of new drugs, particularly those requiring aromatic amine or halogenated intermediates.
Used in Chemical Research:
2-CHLORO-M-PHENYLENEDIAMINE can be utilized in chemical research as a model compound for studying reactions involving aromatic amines and halogenated compounds. Its unique structure provides opportunities for exploring various chemical transformations and understanding reaction mechanisms in organic chemistry.

Upstream product

• 606-21-3 1-chloro-2,6-dinitrobenzene 
• 88-73-3 2-Chloronitrobenzene 

Downstream Products

• 63920-99-0 (2-Chlor-m-phenylendiamino)dimaleinsaeuretetramethylester 
• 53882-09-0 Diethyl N,N'-(2-chloro-m-phenylene)dioxamate 
• 916051-07-5 1,1-dimethylethyl {4-chloro-3-[(4-oxo-4,5-dihydro-1,3-thiazol-2-yl)amino]phenyl}carbamate 
• 916052-00-1 1,1-dimethylethyl 4-{2-[(4-chloro-3-{[(5Z)-4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}phenyl)amino]-2-oxoethyl}-1-piperazinecarboxylate 
• 916051-58-6 2-[3,4-bis(methyloxy)phenyl]-N-(4-chloro-3-{[(5Z)-4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}phenyl)acetamide 
• 916051-87-1 N-(4-chloro-3-{[(5Z)-4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}phenyl)-2-(1-piperidinyl)acetamide 
• 916051-42-8 N-(4-chloro-3-{[(5Z)-4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}phenyl)-N'-(phenylmethyl)urea 
• 916051-72-4 N-(4-chloro-3-{[(5Z)-4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}phenyl)-1-phenylmethanesulfonamide 
• 916051-25-7 N-(4-chloro-3-{[(5Z)-4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}phenyl)-2-(2-thienyl)acetamide 
• 916052-96-5 N-(2-chloro-3-{[(5Z)-4-oxo-5-(6-quinoxalinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}phenyl)cyclobutanecarboxamide 
• 916051-41-7 N-(4-chloro-3-{[(5Z)-4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}phenyl)-2-cyclopropylacetamide 
• 916053-11-7 N-(2-chloro-3-{[(5Z)-4-oxo-5-(6-quinoxalinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}phenyl)benzamide 
• 916052-94-3 N-(2-chloro-3-{[(5Z)-4-oxo-5-(6-quinoxalinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}phenyl)cyclopropanecarboxamide 
• 916052-73-8 4-chloro-N-(2-methylpropyl)-3-{[(5Z)-4-oxo-5-(6-quinoxalinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}benzamide 

Relevant academic research and scientific papers

Iron PCP Pincer Complexes in Three Oxidation States: Reversible Ligand Protonation to Afford an Fe(0) Complex with an Agostic C-H Arene Bond

In the current investigation, the reaction of Fe2(CO)9 with the ligand precursor 2-chloro-N1,N3-bis(diisopropylphosphanyl)-N1,N3-diethylbenzene-1,3-diamine (P(C-Cl)PNEt-iPr) (1)

Reversible Ligand Protonation of a Mn(I) PCP Pincer Complex to Afford a Complex with an η2-Caryl-H Agostic Bond

The first manganese PCP pincer complex, [Mn(PCPNEt-iPr)(CO)3], was obtained by treating [Mn2(CO)10] and 2-chloro-N1,N3-bis(diisopropylphosphanyl)-N1,N3-diethylbenzene-

Method for preparing halogenated aniline from halogenated nitrobenzene through catalytic hydrogenation

The invention discloses a method for preparing halogenated aniline from halogenated nitrobenzene through catalytic hydrogenation. The method comprises the following steps: in a reaction kettle, performing liquid phase catalytic hydrogenation reaction to halogenated nitrobenzene under the action of a sulfur-doped carbon material loaded noble metal catalyst, to obtain halogenated aniline shown in the formula (II), wherein the loading quantity of noble metal in the sulfur-doped carbon material loaded noble metal catalyst is 0.1-5wt%. In the method, the catalyst has good stability, the hydrogenation halogen removal side effect can be effectively inhibited under the condition of having no added halogen removal inhibitor, and the product selectivity is high.

NOVEL CHEMICAL COMPOUNDS

This invention relates to newly identified compounds for inhibiting hYAK3 proteins and methods for treating diseases associated with hYAK3 activity.

Derivatives of 4,6 dioxopyrido[3,2-g]quinoline 2,8 dicarboxylic acid

Novel chemical compounds of the formula: SPC1 Wherein R is selected from the group consisting of hydrogen, alkyl from one to three carbon atoms, inclusive, phenyl, alkali metal, or an amine cation; X and Y can be the same or different and are selected from the group consisting of hydrogen, alkyl of from one to six carbon atoms, inclusive, cycloalkyl of 5 or 6 carbon atoms, inclusive, phenyl, hydroxyl, alkoxy having from one to three carbon atoms, inclusive, halogen, trifluoromethyl, cyano, carboxyamide and O C-OQ, EQU1 where Q is selected from the group consisting of hydrogen, alkyl from one to three carbon atoms, inclusive, alkali metal, and an amine cation, with the proviso that where R is hydrogen, alkali metal or an amine cation, then Q is the same as R, and where R is phenyl or alkyl from one to three carbon atoms, then Q is phenyl or alkyl from one to three carbon atoms; and Z is selected from the group consisting of hydrogen, alkyl from one to three carbon atoms, inclusive, and phenyl. The compounds are formulated with pharmaceutical carriers for oral or parenteral administration, with insufflation being the preferred method. The compositions are useful in the prophylactic treatment of sensitized humans and mammals for allergy and all anaphylactic reactions of a reagin or non-reagin mediated nature.